The effect of immunization on chemokines and CCR5 and CXCR4 coreceptor functions in SIV binding and chemotaxis

Vaccine

Volumn 17, Issue 15-16, 1999, Pages 1826-1836

  Wang, Yufei ^a   Tao, Louisa ^a   Mitchell, Elaine ^a   Bergmeier, Lesley ^a   Doyle, Carl ^a   Lehner, Thomas ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Chemokines; HIV SIV; Mucosa; Vaccine

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4;

ANIMAL CELL; ARTICLE; DRUG EFFECT; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNE RESPONSE; IMMUNIZATION; LYMPHOCYTE COUNT; MONONUCLEAR CELL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; RHESUS MONKEY; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS REPLICATION;

ANIMALS; ANTIBODIES; ANTIGENS, CD8; CHEMOKINES; CHEMOTAXIS, LEUKOCYTE; FEMALE; HIV ENVELOPE PROTEIN GP120; IMMUNIZATION, SECONDARY; LEUKOCYTES, MONONUCLEAR; MACACA MULATTA; MALE; MEMBRANE GLYCOPROTEINS; RECEPTORS, CCR5; RECEPTORS, CXCR4; SAIDS VACCINES; SIMIAN IMMUNODEFICIENCY VIRUS; SUPPRESSOR FACTORS, IMMUNOLOGIC; VACCINATION; VACCINES, SYNTHETIC; VIRAL ENVELOPE PROTEINS; VIRUS REPLICATION;

EID: 0033537855     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(98)00482-4     Document Type: Article

References (36)

1. Clapham P.R., Weber J.N., Whitby D.et al. Soluble CD4 blocks the infectivity of diverse strains of HIV and SIV for T-cells and monocytes but not for brain and muscle cells. Nature. 337:1989;368-370.
2. + T-cells. Science. 270:1995;1811-1815.
3. + cells is mediated by the chemokine receptor CC-CKR-5. Nature. 381:1996;667-673.
4. Deng H., Liu R., Ellmeier W.et al. Identification of a major co-receptor for primary isolates of HIV-1. Nature. 381:1996;661-666.
5. Feng Y., Broder C.C., Kennedy P.E., Berger E.A. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science. 272:1996;872-877.
6. Hirsch V.M., Martin J.E., Dapolito G.et al. Spontaneous substitutions in the vicinity of the V3 analog affect cell tropism and pathogenicity of simian immunodeficiency virus. J. Virol. 68:1994;2649-2661.
7. Kirchhoff F., Mori K., Desrosiers R.C. The V3 domain is determinant of simian immunodeficiency virus cell tropism. J. Virol. 68:1994;3682-3692.
8. Chen Z., Zhou P., Ho D., Landau N.R., Marx P.A. Genetically divergent strains of simian immunodeficiency virus use CCR5 as a coreceptor for entry. J. Virol. 71:1997;2214-2705.
9. Edinger A.L., Amedee A., Miller K.et al. Differential utilization of CCR5 by macrophage and T-cell tropic simian immunodeficiency virus strains. Proc. Natl. Acad. Sci. USA. 94:1997;4005-4010.
10. Hill C.M., Deng H.K., Unutmaz D.et al. Envelope glycoproteins from HIV-1, HIV-2 and SIV can use human CCR5 as a coreceptor for viral entry and make direct CD4-dependent interactions with this chemokine receptor. J. Virol. 71:1997;6296-6304.
11. Marcon L., Choe H., Martin K.A.et al. Utilization of C-C chemokine receptor 5 by the envelope glycoproteins of a pathogenic simian immunodeficiency virus, SIVmac 239. J. Virol. 71:1997;2522-2527.
12. Liao F., Alkhatib G., Peden K.W.C., Sharma G., Berger E.A., Farber J.M. STRL33, a novel chemokine receptors-like protein, functions as a fusion cofactor for both macrophage-tropic and T-cell line-tropic HIV-1. J. Exp. Med. 11:1997;2015-2023.
13. Deng H., Unutmaz D., Kewal-Ramani V.N., Littman D.R. Expression cloning of new receptors used by simian and human immunodeficiency viruses. Nature. 388:1997;296-300.
14. Farzan M., Choe H., Martin K.et al. Two orphan seven-transmembrane segment receptors which are expressed in CD4-positive cells support simian immunodeficiency virus infection. J. Exp. Med. 186:1997;405-411.
15. Pleskoff O., Treboute C., Brelot A., Heveker N., Seman M., Alizon M. Identification of a chemokine receptor encoded by human cytomegalovirus as a cofactor for HIV-1 entry. Science. 276:1997;1874-1878.
16. Choe H., Farzan M., Sun Y.et al. The β-chemokine receptors CCR3 and CCR5 facilitate by primary HIV-1 isolates. Cell. 85:1996;1135-1148.
17. Doranz H., Rucker J., Yi Y.et al. A dual-tropic primary HIV-1 isolate that uses Fusin and the β chemokine receptors CKR-5, CKR-3 and CKR-2b as fusion cofactors. Cell. 85:1996;1149-1158.
18. + cell anti-HIV activity: nonlytic suppression of virus replication. AIDS Res. Hum. Retroviruses. 8:1992;629-640.
19. Lehner T., Wang Y., Cranage M.et al. Protective mucosal immunity elicited by targeted iliac lymph node immunization with a subunit SIV envelope and core vaccine in macaques. Nature (Med). 2:1996;767-775.
20. + T-cell anti-HIV responses in primary HIV-infection. Lancet. 344:1994;1671-1673.
21. + T-cells. Immunol. Today. 17:1996;217-224.
22. Paxton W., Martin S.R., Tse D.et al. Relative resistant to HIV-1 infection of CD4 lymphocytes from persons who remain uninfected despite multiple high-risk sexual exposures. Nature (Med). 2:1996;412-417.
23. + T lymphocytes of african green monkeys secrete an immunodeficiency virus-suppressing lymphokine. Proc. Natl. Acad. Sci. USA. 91:1994;7207-7211.
24. Zou W., Lackner A.A., Simon M.et al. Early cytokine and chemokine gene expression in lymph nodes of macaques infected with simian immunodeficiency virus is predictive of disease outcome and vaccine efficacy. J. Virol. 71:1997;1227-1236.
25. Doyle C.B., Bhattacharyya U., Kent K.A., Stott J.E., Jones I.M. Regions required for CD4 binding in the external glycoprotein gp120 of simian immunodeficiency virus. J. Virol. 69:1995;1256-1260.
26. Lehner T., Bergmeier L.A., Tao L.et al. Targeted lymph node immunization with simian immunodeficiency virus p27 antigen to elicit genital, rectal and urinary immune responses in nonhuman primates. J. Immunol. 153:1994;1858-1868.
27. Bleul C.C., Fuhlbrigge R.C., Casasnovas J.M., Aiuti A., Springer T.A. A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1). J. Exp. Med. 184:1996;1101-1109.
28. Wang Y., Tao L., Mitchell E.et al. Generation of CD8-SF and β chemokines, induced by xenogeneic immunization, in the prevention of SIV infection in macaques. Proc. Natl. Acad. Sci. USA. 95:1998;5223-5228.
29. Bleul C.C., Farzan M., Choe H., Parolin C., Clark-Lewis I., Sodroski J., Springer T.A. The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature. 382:1996;829-833.
30. Oberlin E., Amara A., Bachelerie F.et al. The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1. Nature. 29:1996;833-835.
31. + lymphocytes can control HIV infection in vitro by suppressing virus replication. Science. 234:1986;1563-1566.
32. Cocchi F., DeVico A.L., Garzino-Demo A., Cara A., Gallo R.C., Lusso P. The V3 domain of the HIV gp120 envelope glycoprotein is critical for chemokine-mediated blockade of infection. Nature (Med). 2:1996;1244-1247.
33. Zinkernagel R.M., Ehl S., Aichele P., Oehen S., Kundig T., Hengartner H. Antigen localisation regulates immune responses in a dose- and time-dependent fashion: a geographical view of immune reactivity. Immunol. Rev. 156:1997;199-209.
34. + T-cell phenotype correlates with anti-HIV activity and asymptomatic clinical status. Clin. Immunol. Immunopathol. 69:1993;106-116.
35. Endres M.J., Clapham P.R., Marsh M.et al. CD4-independent infection by HIV-2 is mediated by fusin/CXCR4. Cell. 87:1996;745-756.
36. Amara A., Le Gall S., Schwartz O.et al. HIV coreceptor downregulation as antiviral principle: SDF-1α-dependent internalization of the chemokine receptor CXCR4 contributes to inhibition of HIV replication. J. Exp. Med. 186:1997;139-146.